Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Larsson

Showing results (101-110 of 133) with videos related to

Pageof 14
Sort By:
Scientific Reports|May 16, 2020
Integrative genomics approach identifies molecular features associated with early-stage ovarian carcinoma histotypesHanna Engqvist, Toshima Z Parris, Jana Biermann, et al.
The Journal of General Physiology|May 3, 2021
Identification of PUFA interaction sites on the cardiac potassium channel KCNQ1Samira Yazdi, Johan Nikesjö, Williams Miranda, et al.
BMC Cancer|September 19, 2022
Pan-cancer analysis of genomic and transcriptomic data reveals the prognostic relevance of human proteasome genes in different cancer typesPeter Larsson, Daniella Pettersson, Hanna Engqvist, et al.
Scientific Reports|August 10, 2024
Multi-omics analysis identifies repurposing bortezomib in the treatment of kidney-, nervous system-, and hematological cancersPeter Larsson, Maxim Olsson, Sithumini Sarathchandra, et al.
Scientific Reports|April 4, 2020
Optimization of cell viability assays to improve replicability and reproducibility of cancer drug sensitivity screensPeter Larsson, Hanna Engqvist, Jana Biermann, et al.
European Journal of Pediatrics|June 2, 2022
Incidence of venous thromboembolic events not related to vascular catheters in a prospective cohort of critically ill childrenÅsa K M Östlund, Urban Fläring, Peter Larsson, et al.
British Journal of Anaesthesia|September 25, 2019
Erratum to 'Incidence of and risk factors for venous thrombosis in children with percutaneous non-tunnelled central venous catheters' (Br J Anaesth 2019; 123: 316-24)Åsa Östlund, Urban Fläring, Åke Norberg, et al.
Elife|June 23, 2023
Mechanistic insights into robust cardiac I<sub>Ks</sub> potassium channel activation by aromatic polyunsaturated fatty acid analoguesBriana M Bohannon, Jessica J Jowais, Leif Nyberg, et al.
Cancer Communications (London, England)|November 12, 2025
Pan-cyclin-dependent kinase inhibition is a potential treatment for adenoid cystic carcinoma that downregulates the MYB::NFIB fusion and induces tumor regressionJunchi Huang, Peter Larsson, Maryam Kakay Afshari, et al.
British Journal of Anaesthesia|June 10, 2019
Incidence of and risk factors for venous thrombosis in children with percutaneous non-tunnelled central venous cathetersÅsa Östlund, Urban Fläring, Åke Norberg, et al.
Pageof 14

Showing results (101-110 of 133) with videos related to

Sort By:
Pageof 14
Scientific Reports|May 16, 2020
Integrative genomics approach identifies molecular features associated with early-stage ovarian carcinoma histotypesHanna Engqvist, Toshima Z Parris, Jana Biermann, et al.
The Journal of General Physiology|May 3, 2021
Identification of PUFA interaction sites on the cardiac potassium channel KCNQ1Samira Yazdi, Johan Nikesjö, Williams Miranda, et al.
BMC Cancer|September 19, 2022
Pan-cancer analysis of genomic and transcriptomic data reveals the prognostic relevance of human proteasome genes in different cancer typesPeter Larsson, Daniella Pettersson, Hanna Engqvist, et al.
Scientific Reports|August 10, 2024
Multi-omics analysis identifies repurposing bortezomib in the treatment of kidney-, nervous system-, and hematological cancersPeter Larsson, Maxim Olsson, Sithumini Sarathchandra, et al.
Scientific Reports|April 4, 2020
Optimization of cell viability assays to improve replicability and reproducibility of cancer drug sensitivity screensPeter Larsson, Hanna Engqvist, Jana Biermann, et al.
European Journal of Pediatrics|June 2, 2022
Incidence of venous thromboembolic events not related to vascular catheters in a prospective cohort of critically ill childrenÅsa K M Östlund, Urban Fläring, Peter Larsson, et al.
British Journal of Anaesthesia|September 25, 2019
Erratum to 'Incidence of and risk factors for venous thrombosis in children with percutaneous non-tunnelled central venous catheters' (Br J Anaesth 2019; 123: 316-24)Åsa Östlund, Urban Fläring, Åke Norberg, et al.
Elife|June 23, 2023
Mechanistic insights into robust cardiac I<sub>Ks</sub> potassium channel activation by aromatic polyunsaturated fatty acid analoguesBriana M Bohannon, Jessica J Jowais, Leif Nyberg, et al.
Cancer Communications (London, England)|November 12, 2025
Pan-cyclin-dependent kinase inhibition is a potential treatment for adenoid cystic carcinoma that downregulates the MYB::NFIB fusion and induces tumor regressionJunchi Huang, Peter Larsson, Maryam Kakay Afshari, et al.
British Journal of Anaesthesia|June 10, 2019
Incidence of and risk factors for venous thrombosis in children with percutaneous non-tunnelled central venous cathetersÅsa Östlund, Urban Fläring, Åke Norberg, et al.
Pageof 14